ANA	Anti-nuclear antibodies
aCL	Anti-cardiolipin antibody
ANuA	Anti-nucleosome antibodies
anti-dsDNA	Anti-double-stranded DNA antibody
anti-C1q	Anti-C1q antibody
anti-Jo-1	Anti-histidyl-tRNA synthetase
anti-Ku	Antibodies to Ku protein
anti-La	Anti-La/SSB antibody
anti-PCNA	Anti-proliferating cell nuclear antigen
anti-PM-Scl	Anti-polymyositis/scleroderma antibodies
aPLA	Antiphospholipid antibodies
APS	Antiphospholipid syndrome
anti-RBP	Anti-RNA binding protein
anti-RNP	Anti-ribonucleoprotein
anti-Ro,	Anti-Ro/SSA antibody
anti-Sm	Anti-Smith antibody
anti-SSA	Anti-Sjogren’s syndrome A
anti-SSB	Anti-Sjogren’s syndrome B
BAFF	B cell-activating factor
BILAG	British Isles Lupus Assessment Group
CD	Cluster of differentiation
CLASI	Cutaneous Lupus Erythematosus Disease Area and Severity Index
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
ELISA	Enzyme-linked immunosorbent assays
ENA	Extractable nuclear antigen
HR	Hazard ratio
ICOS	Inducible T cell costimulator
IFN	Type I interferon
IFNAR	Interferon-alpha receptor
IIFA	Indirect immunofluorescence assay
IL-21	Interleukin-21
JAKs	Janus kinases
LLADAS	Lupus low disease activity state
MMF	Mycophenolate mofetil
NET	Neutrophil extracellular trap
pDCs	Plasmacytoid dendritic cells
SELENA-SLEDAI	Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index
SLE	Systemic lupus erythematosus
STAT	Signal transducer and activator of transcription
TLR	Toll-like receptors